Results
Senores Pharmaceuticals FY26 Revenue Up 62% PAT 108%
Senores Pharmaceuticals reported strong FY26 results with revenue growth of 62% to INR664 crore and PAT growth of 108% to INR122 crore.
Management provided FY27 guidance for 30-40% revenue growth and
